Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogiers

Showing results (271-280 of 740) with videos related to

Pageof 74
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Major phase I biotransformation pathways of Trichostatin a in rat hepatocytes and in rat and human liver microsomesG Elaut, G Török, M Vinken, et al.
Contact Dermatitis|June 26, 2002
Evaluation of biophysical and clinical parameters of skin barrier function among hospital workersJean Pierre Hachem, Kristien De Paepe, Guy Sterckx, et al.
Pediatric Transplantation|November 18, 2000
Interleukin-1 receptor antagonist in ascites indicates acute graft rejection after pediatric liver transplantationR Ganschow, B Baade, H H Hellwege, et al.
Critical Reviews in Toxicology|July 2, 2005
Differential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance?Peggy Papeleu, Tamara Vanhaecke, Greetje Elaut, et al.
Alternatives to Laboratory Animals : ATLA|April 13, 2013
Rat hepatocyte suspensions as a suitable in vitro model for studying the biotransformation of histone deacetylase inhibitorsGreetje Elaut, Gabriëlla Török, Peggy Papeleu, et al.
Annals of Surgical Oncology|May 7, 2008
Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor?L Mueller, C Hillert, L Möller, et al.
Journal of Oncology|June 12, 2019
Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint InhibitorsAnne Rogiers, Annelies Boekhout, Julia K Schwarze, et al.
Dermatology (Basel, Switzerland)|July 17, 2001
Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurementsJ P Hachem, K De Paepe, E Vanpée, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|March 10, 2000
[Colorectal liver metastases: does the number of metastases determine of resection is oncologically indicated?]W T Knoefel, C Brunken, E Neumann, et al.
Journal Belge De Radiologie|August 1, 1993
Mesenteric involvement of thromboangiitis obliterans (Buerger's disease) in a womanH Raat, L Stockx, L Broeckaert, et al.
Pageof 74

Showing results (271-280 of 740) with videos related to

Sort By:
Pageof 74
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Major phase I biotransformation pathways of Trichostatin a in rat hepatocytes and in rat and human liver microsomesG Elaut, G Török, M Vinken, et al.
Contact Dermatitis|June 26, 2002
Evaluation of biophysical and clinical parameters of skin barrier function among hospital workersJean Pierre Hachem, Kristien De Paepe, Guy Sterckx, et al.
Pediatric Transplantation|November 18, 2000
Interleukin-1 receptor antagonist in ascites indicates acute graft rejection after pediatric liver transplantationR Ganschow, B Baade, H H Hellwege, et al.
Critical Reviews in Toxicology|July 2, 2005
Differential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance?Peggy Papeleu, Tamara Vanhaecke, Greetje Elaut, et al.
Alternatives to Laboratory Animals : ATLA|April 13, 2013
Rat hepatocyte suspensions as a suitable in vitro model for studying the biotransformation of histone deacetylase inhibitorsGreetje Elaut, Gabriëlla Török, Peggy Papeleu, et al.
Annals of Surgical Oncology|May 7, 2008
Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor?L Mueller, C Hillert, L Möller, et al.
Journal of Oncology|June 12, 2019
Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint InhibitorsAnne Rogiers, Annelies Boekhout, Julia K Schwarze, et al.
Dermatology (Basel, Switzerland)|July 17, 2001
Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurementsJ P Hachem, K De Paepe, E Vanpée, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|March 10, 2000
[Colorectal liver metastases: does the number of metastases determine of resection is oncologically indicated?]W T Knoefel, C Brunken, E Neumann, et al.
Journal Belge De Radiologie|August 1, 1993
Mesenteric involvement of thromboangiitis obliterans (Buerger's disease) in a womanH Raat, L Stockx, L Broeckaert, et al.
Pageof 74